Cancer radio-immunotherapy, integrating external/internal radiation therapy with immuno-
oncology treatments, emerges in the current management of cancer. A growing number of …

Thioredoxin-interacting protein (TXNIP) is a thioredoxin-binding protein that can mediate
oxidative stress, inhibit cell proliferation, and induce apoptosis by inhibiting the function of …

Exosomes are nanoscale monolayer membrane vesicles that are actively endogenously
secreted by mammalian cells. Currently, multifunctional exosomes with tumor-targeted …

Combined treatment of immunotherapy and radiotherapy shows promising therapeutic
effects for the regression of a variety of cancers. However, even multi‐modality therapies …

Immunotherapy is one of the most promising clinical modalities for the treatment of
malignant tumors and has shown excellent therapeutic outcomes in clinical settings …

Thyroid cancer, as one of the most common endocrine cancers, has seen a surge in
incidence in recent years. This is most likely due to the lack of specificity and accuracy of its …

Inert and stable radiolabeling of monoclonal antibodies (mAb), antibody fragments, or
antibody mimetics with radiometals is a prerequisite for immuno-PET. While radiolabeling is …

Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

Theranostics, a promising modern concept combining diagnostic capabilities and
therapeutic effects, has been used for optimizing and personalizing the treatment of many …

Overexpression of CD47 is frequently observed in various types of human malignancies,
inhibiting myeloid-mediated elimination of tumor cells and affecting the prognosis of cancer …